New Study Claims Female Viagra Marginally Effective and Has Multiple Side Effects – International Business Times

Read article - Continued coverage of comments by Lisa Schwartz and Steven Woloshin, both professors of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, from an editorial about their concerns regarding the drug  flibanserin, which was rejected twice by the FDA after findings of weak benefit and potentially serious side effects. (Similar coverage in Parent Herald, Drug Delivery & Development, New Day Post, HCP Live, Scientific American, and JournalStar.)